Market cap
$4 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.9 %
-
ROCE
-- %
-
Industry P/E
37.31
-
EV/EBITDA
0.6
-
Debt to Equity
0
-
Book Value
$5.2
-
EPS
$-5.3
-
Face value
--
-
Shares outstanding
1,753,250
10 Years Aggregate
CFO
$-13.19 Mln
EBITDA
$-14.54 Mln
Net Profit
$-10.40 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Silo Pharma Inc (SILO)
| -- | -42.3 | -- | -- | -55.6 | 0.5 | -16.3 |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
|---|---|
|
Silo Pharma Inc (SILO)
| -57.1 |
|
S&P Small-Cap 600
| 13.9 |
|
BSE Sensex
| 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Silo Pharma Inc (SILO)
|
2.5 | 4.5 | 0.1 | -4.5 | -8,495.0 | -79.9 | -- | 0.9 |
| 17.5 | 6,109.1 | 3,117.6 | 157.4 | 14.7 | -- | 37.3 | 190.1 | |
| 199.0 | 10,424.8 | 776.6 | -191.6 | -17.6 | -223.4 | -- | 129.6 | |
| 76.6 | 14,974.8 | 691.8 | -696.2 | -89.1 | -- | -- | 123.7 | |
| 113.9 | 12,310.3 | 830.8 | 54.9 | 3.2 | 8.1 | 264.8 | 17.9 | |
| 12.2 | 10,087.6 | 332,834.2 | 33,166.6 | 11.1 | 8.9 | 28.8 | 2.5 | |
| 24.1 | 11,971.8 | 5,020.0 | -199.0 | 1.6 | -3 | -- | 1.8 | |
| 280.5 | 5,591.7 | 290.5 | 197.2 | 82.5 | 19.9 | 28.9 | 5.9 | |
| 67.7 | 6,058.9 | 450.9 | 138.6 | 39.1 | 115.6 | 50.1 | 32.1 | |
| 141.4 | 8,865.6 | 431.8 | -136.7 | -30.8 | -30.3 | -- | 21.5 |
Shareholding Pattern
View DetailsAbout Silo Pharma Inc (SILO)
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders,... fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida. Read more
-
Chairman, President & CEO
Mr. Eric Weisblum
-
Chairman, President & CEO
Mr. Eric Weisblum
-
Headquarters
Sarasota, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Silo Pharma Inc (SILO)
What is the current share price of Silo Pharma Inc (SILO) Today?
The share price of Silo Pharma Inc (SILO) is $2.54 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Silo Pharma Inc (SILO) has given a return of -55.64% in the last 3 years.
What is the current PB & PE ratio of Silo Pharma Inc (SILO)?
Since, TTM earnings of Silo Pharma Inc (SILO) is negative, P/E ratio is not available.
The P/B ratio of Silo Pharma Inc (SILO) is 0.91 times as on 28-Aug-2026, a 88 discount to its peers’ median range of 7.75 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-- |
-- |
2024 |
-- |
-- |
2023 |
-0.08 |
0.05 |
2022 |
-0.12 |
0.05 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of Silo Pharma Inc (SILO)?
The 52-week high and low of Silo Pharma Inc (SILO) are Rs 7.95 and Rs 2.44 as of 30-Aug-2026.
What is the market cap of Silo Pharma Inc (SILO)?
Silo Pharma Inc (SILO) has a market capitalisation of $ 4 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Silo Pharma Inc (SILO)?
Before investing in Silo Pharma Inc (SILO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.